Patients
I need help with…
Understanding hereditary cancer risk
What is my risk of developing hereditary cancer?
Treating cancer
What are my treatment options?
Prenatal care
Is my baby at risk for a genetic condition?
Managing mental health
How might my genes affect my medication outcomes?
(sidebar parent)
About genetic testing
What are the costs of genetic testing?
Financial assistance
Patient Resources
How does genetic testing work?
Patient record request
Prostate Cancer
What are my treatment options?
Providers
My patient needs a test for…
Assessing hereditary cancer risk
What is my patient’s risk of developing hereditary cancer?
Cancer treatment
What is the best treatment for my patient?
Prenatal care
What is a pregnancy’s risk of genetic disease?
Mental health treatment
How will my patient metabolize or respond to certain medications?
(sidebar parent)
About our tests
Myriad test catalog
Research & whitepapers
MyRisk
®
gene table
EMR Integrations
Provider resources
Order a test
Order patient materials
Documents & forms
Scope of service & lab certificates
Provider portal
Prostate Cancer Treatment
What are my patient’s treatment options?
Our Tests
Tests for…
(column wrapper)
Prenatal care
Chromosome conditions
Genetic diseases
Cancer risk assessment
Hereditary cancer
Mental health
Depression
Anxiety
ADHD
(column wrapper)
Cancer management
Breast cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Endometrial cancer
Other cancers
All tests
(sidebar parent)
TESTS BY SPECIALTY
Oncology
Urology
Imaging
OB/GYN
Mental Health
Internal/Primary care
All tests
TESTS BY NAME
BRACAnalysis CDx
®
EndoPredict
®
Foresight
®
GeneSight
®
MyChoice
®
CDx
MyRisk
®
(cancer treatment)
MyRisk
®
(cancer risk)
Prequel
®
Precise
™
Tumor
Prolaris
®
About Myriad
Who we are
Our science & innovation
Corporate & social responsibility
Code of Conduct
Supplier Code of Conduct
Latest news
Myriad Genetics Blog
Corporate information
Our leadership
Patient advocacy partners
Investor relations
Careers
Partnerships
Companion diagnostics
PORTAL
ORDER
Search:
Portal
Order
Search:
Patients
I need help with…
Understanding hereditary cancer risk
What is my risk of developing hereditary cancer?
Treating cancer
What are my treatment options?
Prenatal care
Is my baby at risk for a genetic condition?
Managing mental health
How might my genes affect my medication outcomes?
(sidebar parent)
About genetic testing
What are the costs of genetic testing?
Financial assistance
Patient Resources
How does genetic testing work?
Patient record request
Prostate Cancer
What are my treatment options?
Providers
My patient needs a test for…
Assessing hereditary cancer risk
What is my patient’s risk of developing hereditary cancer?
Cancer treatment
What is the best treatment for my patient?
Prenatal care
What is a pregnancy’s risk of genetic disease?
Mental health treatment
How will my patient metabolize or respond to certain medications?
(sidebar parent)
About our tests
Myriad test catalog
Research & whitepapers
MyRisk
®
gene table
EMR Integrations
Provider resources
Order a test
Order patient materials
Documents & forms
Scope of service & lab certificates
Provider portal
Prostate Cancer Treatment
What are my patient’s treatment options?
Our Tests
Tests for…
(column wrapper)
Prenatal care
Chromosome conditions
Genetic diseases
Cancer risk assessment
Hereditary cancer
Mental health
Depression
Anxiety
ADHD
(column wrapper)
Cancer management
Breast cancer
Ovarian cancer
Pancreatic cancer
Prostate cancer
Endometrial cancer
Other cancers
All tests
(sidebar parent)
TESTS BY SPECIALTY
Oncology
Urology
Imaging
OB/GYN
Mental Health
Internal/Primary care
All tests
TESTS BY NAME
BRACAnalysis CDx
®
EndoPredict
®
Foresight
®
GeneSight
®
MyChoice
®
CDx
MyRisk
®
(cancer treatment)
MyRisk
®
(cancer risk)
Prequel
®
Precise
™
Tumor
Prolaris
®
About Myriad
Who we are
Our science & innovation
Corporate & social responsibility
Code of Conduct
Supplier Code of Conduct
Latest news
Myriad Genetics Blog
Corporate information
Our leadership
Patient advocacy partners
Investor relations
Careers
Partnerships
Companion diagnostics
All FAQs
FAQs
- Provider
Can I modify my patient’s order after results are released?
If your patient has recently had a screening with us, please call our Prenatal Support Team at 888-268-6795 or email to make changes to an existing order. Certain order changes require supporting written documentation. Panel change requests must be submitted by the ordering provider in writing by fax or email at
[email protected]
. Once received, updated reports are provided within approximately 72 hours.
Who do I contact to set up a provider portal?
To set up a provider portal with Myriad Women’s Health, please contact your clinic’s account representative. If you do not know who your clinic’s account representative is, please call us at 888-268-6795 or email
[email protected]
for assistance.
I need help with my provider portal, where can I receive assistance?
Your local account representative is ready to assist you with provider portal issues. If you need your account representative’s contact information, please call us at 888-268-6795 or
email
[email protected]
for assistance.
My patient is already pregnant. Can I still order the Foresight
®
Carrier Screen?
While the ideal time for carrier screening is prior to conception, the Foresight® Carrier Screen provides valuable information that can be used to better manage a pregnancy or make treatment decisions.
To avoid the time constraints associated with prenatal diagnostic procedures, we recommend ordering the Foresight® Carrier Screen in tandem with your patient's partner during a pregnancy.
How can I begin offering screens from Myriad Women’s Health in my practice?
Join our growing network of thousands of physicians and we will ship you Myriad Women’s Health sample collection kits completely free of charge. To begin, complete this brief
enrollment form
and specify which products you may be interested in: Foresight
®
Carrier Screen, Prequel
®
Prenatal Screen and myRisk
®
Hereditary Cancer Test. We are happy to send a local Myriad Women’s Health representative to your practice to provide more information, set up an account and help you use Myriad Women’s Health routinely. Simply
submit a request
and our team will reach out to you shortly.
Back to all FAQs
New Guidelines from AUA and ASTRO Support Inclusion of Genomic Testing in Localized Prostate Cancer
New Guidelines from AUA and ASTRO Support Inclusion of Genomic Testing in Localized Prostate Cancer
Click here for webcast
Locations
United States
Europe
Japan